Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters

PHASE2RecruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Neurogenic Bladder
Interventions
DRUG

Culturelle 10 Billion CFU Capsule

"LGG® (Culturelle Probiotic with Lactobacillus RhamnosusGG, shown to produce the largest amount of antibacterial substances against pathogenic bacteria) will be used. For the LGG® instillation, participants will be instructed to mix the contents of 1 LGG capsule into 45 cc sterile 0.9% saline. After mixing, participants will draw up the 45cc liquid LGG mixture into a 60cc syringe and instill via the indwelling catheter (the catheter will not be changed as this would represent 2 interventions). Participants will be instructed the plug their catheter for 1 hour. Participants will receive 2 or 4 LGG capsules (depending on randomization group) and will repeat this process the following day (Low dose) or twice daily for a total of four doses (High dose) according to randomization group."

Trial Locations (1)

20010

RECRUITING

MedStar National Rehabilitation Hospital, Washington D.C.

All Listed Sponsors
collaborator

Children's National Research Institute

OTHER

lead

Medstar Health Research Institute

OTHER